Products

Title
Magnesium sulfate heptahydrate injection
Strength 100 mg/ml, 200 mg/ml, 250 mg/ml
Volume 10 ml
ATC code A12CC02

Other mineral supplements

Additional Strength: 500 mg/ml (WHO prequalified) 2 ml and 10 ml

This medicine is used for:
- Treatment and prevention of hypomagnesaemia in clinical conditions which may be associated with magnesium deficiency such as prolonged diarrhoea, diabetes mellitus, malabsorption syndromes, alcoholism, cirrhosis of the liver, during pregnancy and breast-feeding period, in case of renal diseases with polyuria, as well as during administration of “loop” diuretics;
- Prevention and treatment of hypomagnesaemia in patients on total parenteral nutrition;
- Seizure prevention (e. g. epilepsy, uraemia in patients with nephropathy);
- Prevention and treatment of pre-eclampsia and eclampsia in late pregnancy toxemia, as well as to stop spontaneous abortion and preterm labour;
- Treatment of the early stages of arterial hypertension as antispasmodic medicine;
- Prevention of arrhythmias (e. g. torsade de pointes-type arrhythmias, arrhythmias with signs of hypokalemia).

Metamizole sodium monohydrate injection
Strength 500 mg/ml
Volume 2 ml, 5 ml
ATC code N02BB02

ANALGESICS, OTHER ANALGESICS AND ANTIPYRETICS

This medicine is used for treatment of severe acute or chronic pain. Fever not responding to other treatment.

Midazolam injection
Strength 1 mg/ml, 5 mg/ml
Volume 1 ml, 3 ml, 5 ml, 10 ml
ATC code N05CD08

HYPNOTICS AND SEDATIVES

This medicine is a short-acting hypnotic with the following indications for use:

Adults
• CONSCIOUS SEDATION with or without local anaesthesia before or during diagnostic or therapeutic procedures
• ANAESTHESIA
- Premedication before the induction of anaesthesia
- Induction of anaesthesia
- As a sedative component in maintenance of anaesthesia
• SEDATION IN THE INTENSIVE CARE UNIT

Children
• CONSCIOUS SEDATION with or without local anaesthesia before or during diagnostic or therapeutic procedures
• ANAESTHESIA
- Premedication before the induction of anaesthesia
• SEDATION IN THE INTENSIVE CARE UNIT

Mivacurium injection
Strength 2 mg/ml
Volume 5 ml, 10 ml
ATC code M03AC10

MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS

Mivacurium is a highly selective, short-acting, non-depolarising neuromuscular blocking agent with a fast recovery profile.
Mivacurium is indicated as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation in adults, children and infants 2 months and over.

Morphine hydrochloride injection
Strength 10 mg/ml, 20 mg/ml
Volume 1 ml, 5 ml, 10 ml
ATC code N02AA01

ANALGESIC, OPIOID

This medicine is used for treatment of severe pain conditions which can be adequately managed only with opioid analgesics. Myocardial infarction, acute pulmonary oedema.

Morphine prolonged release tablets*
Strength 10 mg, 30 mg, 60 mg, 100 mg
ATC code N02AA01

Analgesics, Opioids

Morphine sulfate injection (w/o preservatives)
Strength 2 mg/ml, 5 mg/ml, 10 mg/ml, 15 mg/ml, 30 mg/ml
Volume 1 ml
ATC code N02AA01

ANALGESIC, OPIOID

This medicine is used for the relief of severe pain. It is also used to treat breathlessness caused by fluid in the lungs and as a pre-medication before operations.